Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.
As the pharmacy industry continues to rapidly evolve, inevitably there will be many challenges to overcome. Among the biggest difficulties pharmacists face today are reimbursement pressures, a lack of standardization, fragmented data, and the struggle to deliver the best quality of care while simultaneously increasing the volume of care.
At the Total Pharmacy Solutions Summit Summer 2024, held virtually on July 13, 2024, Emily Endres, BSPS, vice president of pharmacy at Innovaccer, hosted a session titled “Strategies for Pharmacy Success: Navigating the Evolving Health Care Landscape and Unlocking Alternate Revenue Streams.” Endres discussed the evolution of health care, as well as the knowledge and skills that pharmacy professionals need to adapt to the changing environment.
“You can’t understand where you’re going if you don’t know where you have been,” Endres said during her presentation. “And what history tells us is that change in this industry is continuous, it’s expected, and it’s necessary. On the other side of that change will come some growth. What I think is really impactful about the history of our profession and this industry is that if you think about it, in all of those eras, quality and care have been at the foundation of all of those changes.”
READ MORE: Use MTM and Patient Engagement Solutions to Increase Profits
Read more articles from the Total Pharmacy October 2024 issue and visit drugtopics.com/TPSSSummer2024 to watch all the Total Pharmacy Solutions Summit sessions on demand.
Pharmacy practice is always changing. Stay ahead of the curve: Sign up for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips, straight to your inbox.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
2 Commerce Drive
Cranbury, NJ 08512